Study of Oral MRT-2359 in Selected Cancer Patients
A phase 1/2 trial of Oral MRT-2359 in non-small-cell lung cancer, small-cell lung cancer, neuroendocrine tumours, HR-positive / HER2-negative breast cancer and prostate cancer, run by Monte Rosa Therapeutics, Inc, active and no longer recruiting.
Overview
Study of Oral MRT-2359 in Selected Cancer Patients is a phase 1/2 interventional study registered as NCT05546268 by Monte Rosa Therapeutics, Inc, with 174 participants enrolled, started 2022-10-12 and due to reach its primary completion in 2026-05. Interventions recorded: Oral MRT-2359.
Similar pages
not linked directly; found by shared links- TrialA Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
Shares Neuroendocrine tumours, Small-cell lung cancer and the tag pipeline.
- TrialDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Shares Neuroendocrine tumours, Small-cell lung cancer and the tag pipeline.
- TrialTT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Shares Prostate cancer, Non-small-cell lung cancer and the tag pipeline.
- TreatmentPF-07248144
Shares Prostate cancer, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer and the tag pipeline.
- TrialFirst in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tag pipeline.
- TrialPhase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tag pipeline.
- TrialA First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tag pipeline.
- TrialStudy of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tag pipeline.